NCT05609019View on ClinicalTrials.gov

A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

December 31, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Advanced Solid Tumors
Interventions
DRUG

SYHX2005

Tablets. Take orally.

Sponsors
All Listed Sponsors
lead

CSPC Ouyi Pharmaceutical Co., Ltd.

INDUSTRY

NCT05609019 - A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter